Role of orexin/hypocretin in reward-seeking and addiction: Implications for obesity

Physiology and Behavior

Volumn 100, Issue 5, 2010, Pages 419-428

  Cason, Angie M ^a   Smith, Rachel J ^a   Tahsili Fahadan, Pouya ^a   Moorman, David E ^a   Sartor, Gregory C ^a   Aston Jones, Gary ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Addiction; Conditioned stimuli; Obesity; Orexin; Palatable food; Reward based feeding

Indexed keywords

ALCOHOL; COCAINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; OREXIN; PROTEIN FOS;

ABSTINENCE; ADDICTION; ALCOHOL CONSUMPTION; ARTICLE; DIETARY INTAKE; EXPERIMENTAL RAT; FEEDING BEHAVIOR; HYPOTHALAMUS NUCLEUS; INTERMETHOD COMPARISON; LATERAL HYPOTHALAMUS; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REWARD; STIMULUS RESPONSE;

ANIMALS; BEHAVIOR, ADDICTIVE; FOOD PREFERENCES; HUMANS; HYPOTHALAMIC AREA, LATERAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; OBESITY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; REWARD;

EID: 77953710614     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.03.009     Document Type: Article

References (95)

1. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U. S. A. 1998, 95:322-327.
2. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
3. Zhu Y., Miwa Y., Yamanaka A., Yada T., Shibahara M., Abe Y., et al. Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins. J Pharmacol Sci 2003, 92:259-266.
4. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
5. Sutcliffe J.G., de Lecea L. The hypocretins: setting the arousal threshold. Nat Rev Neurosci 2002, 3:339-349.
6. Kilduff T.S., de Lecea L. Mapping of the mRNAs for the hypocretin/orexin and melanin-concentrating hormone receptors: networks of overlapping peptide systems. J Comp Neurol 2001, 435:1-5.
7. Lu X.Y., Bagnol D., Burke S., Akil H., Watson S.J. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 2000, 37:335-344.
8. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001, 435:6-25.
9. Trivedi P., Yu H., MacNeil D.J., Van der Ploeg L.H., Guan X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 1998, 438:71-75.
10. Haynes A.C., Jackson B., Chapman H., Tadayyon M., Johns A., Porter R.A., et al. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Peptides 2000, 96:45-51.
11. Ishii Y., Blundell J.E., Halford J.C., Upton N., Porter R., Johns A., et al. Differential effects of the selective orexin-1 receptor anagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats. Physiol Behav 2004, 81:129-140.
12. Ishii Y., Blundell J.E., Halford J.C., Upton N., Porter R., Johns A., et al. Satiety enhancement by selective orexin-1 receptor anagonist SB-334867: influence of test context and profile comparison with CCK8-S. Behav Brain Res 2005, 160:11-24.
13. Rodgers R.J., Halford J.C., Nunes de Souza R.L., Canto de Souza A.L., Arch J.R., Blundell J.E. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept 2000, 96:71-84.
14. Rodgers R.J., Halford J.C., Nunes de Souza R.L., Canto de Souza A.L., Piper D.C., Arch J.R., et al. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J NeuroSci 2001, 13:1444-1452.
15. Yamanaka A., Sakurai T., Katsumoto T., Yanagisawa M., Goto K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res 1999, 849:248-252.
16. Broberger C., de Lecea L., Sutcliffe J.G., Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent hypothalamus: relationship to neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 1998, 402:460-474.
17. Horvath T.L., Peyron C., Sabrina D., Ivanov A., Aston-Jones G., Kilduff T., et al. Strong hypocretin (orexin) innervation of the locus coeruleus activates noradrenergic cells. J Comp Neurol 1999, 415:145-159.
18. Yamanaka A., Kunii K., Nambu T., Tsujino N., Sakai S., Matsuzaki I., et al. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res 2000, 859:404-409.
19. Yamamoto Y., Ueta Y., Date Y., Nakazato M., Hara Y., Serino R., et al. Down regulation of the prepro-orexin gene expression in genetically obese mice. Brain Res Mol Brain Res 1999, 65:14-22.
20. White C.L., Ishii Y., Mendoza T., Upton N., Stasi L.P., Bray G.A., et al. Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity. Peptides 2005, 26:2331-2338.
21. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
22. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
23. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39-40.
24. Nishino S. Clinical and neurobiological aspects of narcolepsy. Sleep Med 2007, 8:373-399.
25. Thannickal T.C., Nienhuis R., Siegel J.M. Localized loss of hypocretin (orexin) cells in narcolepsy with cataplexy. Sleep 2009, 32:993-998.
26. Bayer L., Eggermann E., Serafin M., Saint-Mleux B., Machard D., Jones B., et al. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J NeuroSci 2001, 14:1571-1575.
27. Eggermann E., Serafin M., Bayer L., Machard D., Saint-Mleux B., Jones B.E., et al. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001, 108:177-181.
28. Eriksson K.S., Sergeeva O., Brown R.E., Haas H.L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001, 21:9273-9279.
29. Ivanov A., Aston-Jones G. Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons. NeuroReport 2000, 11:1755-1758.
30. Aston-Jones G., Smith R.J., Moorman D.E., Richardson K.A. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 2009, 56:112-121.
31. Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P, Richardson KA. Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction. Brain Res 2010;1314:74-90.
32. Borgland SL, Ungless MA, Bonci A. Convergent actions of orexin/hypocretin and CRF on dopamine neurons: emerging players and addiction. Brain Res 2010;1314:139-44.
33. Sharf R, Sarhan M, Dileone RJ. Role of orexin/hypocretin in dependence and addiction. Brain Res 2010;1314:130-8.
34. Volkow N.D., Wise R.A. How can drug addiction help us understand obesity?. Nat Neurosci 2005, 8:555-560.
35. Will M.J., Franzblau E.B., Kelley A.E. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 2003, 123:2882-2888.
36. Zheng H., Berthoud H.R. Eating for pleasure or calories. Curr Opin Pharmacol 2007, 7:607-612.
37. Zheng H., Patterson L.M., Berthoud H.-R. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J Neurosci 2007, 27:11075-11082.
38. Stratford T.R., Kelley A.E. Evidence of a functional relationship between the nucleus accumbens shell and lateral hypothalamus subserving the control of feeding behavior. J Neurosci 1999, 19:11040-11048.
39. Baldo B.A., Gual-Bonilla L., Sijapati K., Daniel R.A., Landry C.F., Kelley A.E. Activation of a subpopulation of orexin/hypocretin-containing hypothalamic neurons by GABA A receptr-mediated inhibition of the nucleus accumbens shell, but not by exposure to a novel environment. Eur J NeuroSci 2004, 19:376-386.
40. Thorpe A.J., Cleary J.P., Levine A.S., Kotz C.M. Centrally administered orexin A increases motivation for sweet pellets in rats. Psychopharmacol (Berl) 2005, 182:75-83.
41. Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., et al. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evan rats. Psychopharmacol (Berl.) 2008, 199:109-117.
42. Cason A.M., Fallon R., Aston-Jones G. Effects of the orexin/hypocretin 1 receptor antagonist SB-334867 on sucrose-seeking in rats. 755.10 2009 Neuroscience meeting planner 2009, Society fo Neuroscience, Chicago, IL, Online.
43. Smith R., See R., Aston-Jones G. Orexin/hypocretin signaling at the OX1 receptor regulates cue-elicited cocaine-seeking. Eur J NeuroSci 2009, 30:493-503.
44. Nair S.G., Golden S.A., Shaham Y. Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats. Br J Pharmacol 2008, 154:406-416.
45. Borgland S.L., Chang S.J., Bowers M.S., Thompson J.L., Vittoz N., Floresco S.B., et al. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 2009, 29:11215-11225.
46. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
47. Dayas C.V., McGranahan T.M., Martin-Fardon R., Weiss F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol Psychiatry 2008, 63:152-157.
48. Aston-Jones G., Liu S. Increased preference for cocaine during protracted forced abstinence: relationship with orexin/hypocretin neurons. Program no. 63.18, 2008 neuroscience meeting planner 2008, Society for Neuroscience, Washington, DC, Online.
49. Castellanos E.H., Charboneau E., Dietrich M.S., Park S., Bradley B.P., Mogg K., et al. Obese adults have visual attention bias for food cue images: evidence for altered reward system function. Int J Obes (London) 2009, 33:1063-1073.
50. Moore H., Sater M., Bruno J.P. Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazephine receptor ligands. Brain Res 1993, 627:267-274.
51. Inglis F.M., Day J.C., Fibiger H.C. Enhanced acetylcholine release in hippocampus and cortex during anticipation and consumption of a palatable meal. Neuroscience 1994, 62:1049-1056.
52. Fadel J., Moore H., Sarter M., Bruno J.P. Trans-synaptic stimulation of cortical acetylcholine release after partial 192 IgG-saporin-induced loss of cortical cholinergic afferents. J Neurosci 1996, 16:6592-6600.
53. Frederick-Duus D., Guyton M.F., Fadel J. Food-elicited increases in cortical acetylcholine release require orexin transmission. Neuroscience 2007, 149:499-507.
54. McLaughlin R.J., Floresco S.B. The role of different subregions of the basolateral amygdala in cue-induced reinstatement and extinction of food-seeking. Neuroscience 2007, 146(4):1484-1494.
55. Floresco S.B., McLaughlin R.J., Haluk D.M. Opposing roles for the nucleus accumbens core and shell in cue-induced reinstatement of food-seeking behavior. Behav Brain Res 2008, 190(1):85-96.
56. Petrovich G.D., Setlow B., Holland P.C., Gallagher M. Amygdalo-hypothalamic circuit allows learned cues to override satiety and promote eating. J Neurosci 2002, 22:8748-8753.
57. Kirouac G.J., Ganguly P.K. Topographical organization of the nucleus accumbens afferents from the basolateral amygdala and efferents to the lateral hypothalamus. Neuroscience 1995, 67(3):625-630.
58. Hamlin A.S., Blatchford K.E., McNally G.P. Renewal of an extinguished instrumental response: neural correlates and the role of D1 dopamine receptors. Neuroscience 2006, 143(1):25-38.
59. Marchant N.J., Hamlin A.S., McNally G.P. Lateral hypothalamus is required for context-induced reinstatement of extinguished reward seeking. J Neurosci 2009, 29:1331-1342.
60. Crombag H.S., Grimm J.W., Shaham Y. Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues. Neuropsychopharmacology 2002, 27:1006-1015.
61. Fuchs R.A., Evans K.A., Ledford C.C., Parker M.P., Case J.M., Mehta R.H., et al. The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 2005, 30:296-309.
62. Sharf R, Guarnieri DJ, Taylor JR, Dileone RJ. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization. Brain Res 2010;1317:24-32.
63. Smith R.J., Tahsili-Fahadan P., Aston-Jones G. Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology 2010, 58(1):179-184.
64. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 2006, 148:752-759.
65. Akanmu M.A., Honda K. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats. Brain Res 2005, 1048:138-145.
66. Willie J.T., Chemelli R.M., Sinton C.M., Tokita S., Williams S.C., Kisanuki Y.Y., et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 2003, 38:715-730.
67. Dugovic C., Shelton J.E., Aluisio L.E., Fraser I.C., Jiang X., Sutton S.W., et al. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther 2009, 330:142-151.
68. Malherbe P, Borroni E, Gobbi L, Knust H, Nettekoven M, Pinard E, Roche O, Rogers-Evans M, Wettstein JG, Moreau JL. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor. Br J Phrarmacol 2009;156:1326-1341.
69. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U. S. A 2005, 102:19168-19173.
70. Hollander J.A., Lu Q., Cameron M.D., Kamenecka T.M., Kenny P.J. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U. S. A. 2008, 24:24.
71. Moorman D.E., Aston-Jones G. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague Dawley rats. Alcohol 2009, 43:379-386.
72. Simms J.A., Steensland P., Medina B., Abernathy K.E., Chandler L.J., Wise R., et al. Intermittent access to 20% ethanol induced high ethanol consumption in Long-Evans and Wistar rats. Alcohol Clin Exp Res 2008, 32:1816-1823.
73. Aston-Jones G., Harris G.C. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 2004, 47(S1):167-179.
74. Harris G.C., Aston-Jones G. Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal. Neuropsychopharmacology 2001, 24:75-85.
75. Harris G.C., Aston-Jones G. Enhanced morphine preference following prolonged abstinence: association with increased Fos expression in the extended amygdala. Neuropsychopharmacology 2003, 28:292-299.
76. Harris G.C., Aston-Jones G. Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregulation of reward processing. Neuropsychopharmacology 2003, 28:865-871.
77. Harris G.C., Wimmer M., Randall-Thompson J.F., Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res 2007, 183:43-51.
78. Jaffe J.H., Gilman A.G., Ralls T.W., Nies A.S., Taylor P. Drug addiction and drug abuse. The pharmacological basis of therapeutics 1990, 522-573. Pergamon Press, New York.
79. Harris G., Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci 2006, 29:571-577.
80. Estabrooke I.V., McCarthy M.T., Ko E., Chou T.C., Chemelli R.M., Yanagisawa M., et al. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001, 21:1656-1662.
81. Fadel J., Bubser M., Deutch A.Y. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J Neurosci 2002, 22:6742-6746.
82. Sharf R., Sarhan M., Dileone R.J. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 2008, 64:175-183.
83. Fadel J., Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002, 111:379-387.
84. Yoshida K., McCormack S., Espana R.A., Crocker A., Scammell T.E. Afferents to the orexin neurons of the rat brain. J Comp Neurol 2006, 494:845-861.
85. Richardson K.A., Knackstedt P.T., Aston-Jones G. Orexin neurons that project to the ventral tegmental area (VTA) are activated by morphine preference during protracted forced abstinence. Program no. 916.4. 2007 neuroscience meeting planner 2007, Society for Neuroscience, San Diego, CA, Online.
86. Richardson K.A., Knackstedt P.T., Aston-Jones G. Activation of VTA-projecting orexin/hypocretin neurons in the lateral, but not the dorsomedial and perifornical hypothalamus, correlates with morphine preference after prolonged forced abstinence. Program no. 63.16. 2008 neuroscience meeting planner 2008, Society for Neuroscience, Washington, DC, Online.
87. Richardson K.A., Aston-Jones G. Morphine conditioning activates orexin/hypocretin neurons that project to rostral VTA: effects of protracted abstinence. Program no. 751.12. 2009 neuroscience meeting planner 2009, Society for Neuroscience, Chicago, IL, Online.
88. Sartor G.C., Aston-Jones G., Sartor G.C., Aston-Jones G. Afferents that regulate lateral hypothalamic orexin/hypocretin neurons during drug seeking behaviors. Program no. 63.13. 2008 neuroscience meeting planner 2008, Society for Neuroscience, Washington, DC, Online.
89. Sartor G.C., Aston-Jones G., Sartor G.C., Aston-Jones G. Afferents that regulate lateral hypothalamic orexin neurons during drug-seeking behaviors. Program no. 253.15. 2009 neuroscience meeting planner 2009, Society for Neuroscience, Chicago, IL, Online.
90. Schroeder B.E., Binzark J.M., Kelley A.E. A common profile of prefrontal cortical activation following exposure to nicotine- or chocolate-associated contextual cues. Neuroscience 2001, 105:535-545.
91. Schroeder B.E., Kelley A.E. Conditioned Fos expression following morphine-paired contextual cue exposure is environment specific. Behav Neurosci 2002, 116:727-732.
92. Schroeder B.E., Schiltz C.A., Kelley A.E. Neural activation profile elicited by cues associated with the anxiogenic drug yohimbine differs from that observed for reward-paired cues. Neuropsychopharmacology 2003, 28:14-21.
93. Kelley A.E., Schlitz C.A., Landry C.F. Neural systems recruited by drug- and food-related cues: studies of gene activation in corticolimbic regions. Physiol Behav 2005, 86:11-14.
94. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., et al. Direct involvement of orexigenic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006, 26:398-405.
95. Moorman D.E., Aston-Jones G. Modulation of ventral tegmental area neural responses to prefrontal stimulation by local orexin application in vivo. Program no. 916.2. 2007 neuroscience meeting planner 2007, Society for Neuroscience, San Diego, CA, Online.